ET Healthcare vs Cradle
Side-by-side comparison of AI visibility scores, market position, and capabilities
Isotachophoresis-Based Sample Preparation for Diagnostics & Research
ET Healthcare develops isotachophoresis (ITP) technology for rapid, automated nucleic acid and biomarker sample preparation in life sciences research and diagnostics; enables faster processing with minimal sample volumes;
About
ET Healthcare is a Menlo Park, California-based life sciences instrumentation company that develops sample preparation technology based on isotachophoresis (ITP) — an electrokinetic technique that concentrates and purifies nucleic acids, proteins, and other biomolecules from complex biological samples without centrifugation or column-based purification steps. ITP uses electric fields to focus and separate analytes by their electrophoretic mobility, enabling very rapid (often sub-10-minute) purification from small sample volumes with minimal hands-on steps.
AI protein design platform combining language models with lab automation; active learning cycles for enzyme, antibody, and therapeutic protein engineering optimization.
About
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, activity, and manufacturability. Founded in 2021 and headquartered in Amsterdam with teams in San Francisco, Cradle raised approximately $24 million and targets biopharmaceutical, agricultural, and industrial biotechnology companies that need to engineer proteins with specific functional properties.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.